6 research outputs found
Indicència i supervivència del cà ncer de cap i coll a la demarcació de Tarragona (1980-2005)
- Contribucions i coneixements nous que aporta la tesi:
Es tracta d’un estudi epidemiològic descriptiu de les neoplà sies malignes de cap i coll
a la demarcació de Tarragona (609.673 habitants l’any 2001). S’analitza la
incidència, la mortalitat, la supervivència i la prevalença en base poblacional de les
3.507 neoplĂ sies de cap i coll del Registre de CĂ ncer de Tarragona, durant el perĂode
1980-2005 (609 cĂ ncers de llavi, 410 de llengua, 374 de cavitat oral, 142 de glĂ ndules
salivals, 140 d’amĂgdala, 118 de nasofaringe, 239 d’hipofaringe, 122 d’altres llocs de
la cavitat oral i faringe, 87 de cavitats nasals i sins paranasals i 1.266 de laringe).
- Metodologia emprada:
S’ha utilitzat la metodologia pròpia dels registres de cà ncer de base poblacional
seguint els criteris de la International Agency for Research on Cancer (IARC), per
assegurar tant una bona cobertura dels casos com una bona precisiĂł de les dades.
S’avaluen els Ăndexs de qualitat estĂ ndard que resulten adequats pel al conjunt i per
a cadascuna de les localitzacions.
- Resultats
S’ha estudiat la tendència temporal de la incidència i la seva projecció a 2010 i 2015.
Tots els resultats estan referits pel total dels cĂ ncers de cap i coll i per a cadascuna
de les 10 localitzacions.
Destaca la taxa ajustada d’incidència del cà ncer de laringe en homes que és de les
més altes del món.
S’han fet comparacions internacionals de la incidència i de la supervivència. La
supervivència s’ha mantingut estable i és similar a la del conjunt d’Europa.
- Conclusions més rellevants:
Les principals conclusions han estat que les neoplĂ sies de cap i coll mostren un patrĂł
epidemiològic occidentalitzat, similar especialment al sud d’Europa. Hi ha una
reducció global en la tendència temporal de la incidència en els homes que es
correlaciona amb la disminució del tabaquisme. S’observa un augment en
localitzacions com l’amĂgdala que es correlaciona amb l’exposiciĂł al virus del
papil=loma humĂ .
Malgrat les millores diagnòstiques i terapèutiques dels últims anys, igual que a
Europa, no s’observa una millora significativa de la supervivència relativa en base
poblacional a Tarragona.
- Comunicacions a congressos:
Laryngeal cancer in Tarragona cancer registry (TCR) Spain. Relative survival by age
and stage (pòster). E. Mur, M. Bonet, A. Ameijide, T. Bonfill, J. Borrà s. 3rd
International Conference on Innovative Approaches in Head & Neck Oncology.
Barcelona, febrer de 2011This is a descriptive epidemiological study of head and neck malignancies in
Tarragona province (609,673 inhabitants in 2001). Data of population-based
incidence, mortality, survival and prevalence, were analyzed concerning 3,507 head
and neck malignancies recorded in the Tarragona Cancer Registry during the period
1980 to 2005 (609 lip cancer, 410 tongue, 374 oral cavity, 142 salivary glands, 140
tonsil, 118 nasopharyngeal, 239 hypopharyngeal, 122 others of oral cavity and
pharynx, 87 nasal cavities and sinus and 1,266 laryngeal cancer).
The methodology of population-based cancer registries has been applied, following
the criteria of the International Agency for Research on Cancer (IARC), in order to
ensure both completeness and accuracy of data.
Evaluation of the standard quality indices showed that they were appropriate for the
anatomical sites studied, both individually and collectively.
The temporal trend in incidence has been studied and its projection to 2010 and 2015
estimated. Results are referred by total head and neck and by one out of every ten
localizations.
It is emphasized that the age-adjusted incidence rate of laryngeal cancer in men is
one of the highest in the world.
International comparisons of the incidence and survival have been made. The survival
rate has remained stable, and is similar to the rest of Europe
The main conclusions are that the head and neck malignancies in Tarragona show a
westernized epidemiological pattern, similar to Southern Europe. There is an overall
reduction in the time trend of incidence in men, correlated with the reduction in
tobacco consumption. The increasing trend in sites such as tonsil, has been
correlated with the exposure to human papilloma virus.
As in the rest of Europe, improvements in population-based relative survival was not
observed, despite diagnostic and therapeutic advances in recent years
Incidència i supervivència del cà ncer de cap i coll a la demarcació de Tarragona (1980–2005)
Estudi epidemiològic descriptiu dels cĂ ncers de cap i coll a la demarcaciĂł de Tarragona. S’hi analitza la incidència, la mortalitat, la supervivència i la prevalença en base poblacional de les 3.507 neoplĂ sies de cap i coll del Registre de CĂ ncer de Tarragona, durant el perĂode 1980–2005, per a cadascuna de les localitzacions (llavi, llengua, cavitat oral, glĂ ndules salivals, amĂgdala, nasofaringe, hipofaringe, altres llocs de la cavitat oral i faringe, cavitat nasals i sins paranasals i laringe)
Are breast cancer patients treated with radiotherapy younger now than ten years ago?
AimThe aim of the present study was to analyze the age of breast cancer patients managed with curative approach at the time of treatment with radiotherapy.BackgroundBreast cancer is the most frequent neoplasm in women. Little is known with regard to the age of patients at diagnosis, and some authors have suggested that breast cancer is now affecting women who are younger than before.Materials and methodsWe performed a descriptive study of our series of breast cancer patients from 1998 to 2011. The age of patients, city of residence, year of treatment and uni- or bilateral location were extracted from the administrative database of the Radiation Oncology Department. The demographical and reference populational data were extracted from the Catalan Institute of Statistics.Results3382 patients were obtained. The mean age was 57.79 years. No statistical differences were observed in the mean age during the period of study (p[[ce:hsp sp="0.25"/]]>[[ce:hsp sp="0.25"/]]0.05), nor in patients with bilateral neoplasias with regard to unilateral tumours (p[[ce:hsp sp="0.25"/]]>[[ce:hsp sp="0.25"/]]0.5). Patients aged less than 30, 40, 50 and 65 years were 0.3%, 6.3%, 27.0% and 69.1%, respectively. The proportion of patients aged less, equal or more than 40 and 50 years was not statistically different.ConclusionsBreast cancer patients treated with adjuvant radiotherapy after radical surgery have not experienced significant changes in their mean age at treatment. The subgroups of patients that remain out of the mammographic screening programmes were unchanged as well. The observed differences can be explained by demographical disparities and by a probable increase in the indications for adjuvant radiotherapy